US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 6.740
  • -0.220-3.16%
Close Aug 16 16:00 ET
  • 6.740
  • 0.0000.00%
Post 16:02 ET
290.81MMarket Cap-3173P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
24.20%7.03M
282K
5.66M
Operating revenue
--0
--0
--0
--0
--0
--0
--0
24.20%7.03M
--282K
--5.66M
Cost of revenue
Gross profit
Operating expense
151.35%33.44M
156.51%29.36M
71.40%62.41M
136.03%21.38M
16.28M
13.3M
11.45M
13.77%36.41M
9.06M
32M
Selling and administrative expenses
111.05%6.11M
151.72%6.88M
55.90%12.48M
111.76%4.21M
--2.64M
--2.9M
--2.73M
30.20%8.01M
--1.99M
--6.15M
-General and administrative expense
111.05%6.11M
151.72%6.88M
55.90%12.48M
111.76%4.21M
--2.64M
--2.9M
--2.73M
30.20%8.01M
--1.99M
--6.15M
Research and development costs
162.58%27.32M
158.02%22.48M
75.77%49.92M
142.86%17.16M
--13.64M
--10.41M
--8.71M
9.86%28.4M
--7.07M
--25.85M
Operating profit
-151.35%-33.44M
-156.51%-29.36M
-112.38%-62.41M
-143.61%-21.38M
-16.28M
-13.3M
-11.45M
-11.53%-29.38M
-8.78M
-26.35M
Net non-operating interest income expense
2,035.32%4.66M
782.30%2.69M
319.00%2.1M
189.84%742K
830K
218K
305K
25,100.00%500K
256K
-2K
Non-operating interest income
1,678.03%4.69M
683.67%2.74M
303.89%2.28M
165.66%789K
--880K
--264K
--349K
56,400.00%565K
--297K
--1K
Non-operating interest expense
-15.22%39K
0.00%44K
187.69%187K
14.63%47K
--50K
--46K
--44K
2,066.67%65K
--41K
--3K
Other net income (expense)
-228.57%-23K
-766.67%-26K
-511.11%-55K
-239.13%-32K
-13K
-7K
-3K
-350.00%-9K
23K
-2K
Other non- operating income (expenses)
-228.57%-23K
-766.67%-26K
-511.11%-55K
-239.13%-32K
---13K
---7K
---3K
-350.00%-9K
--23K
---2K
Income before tax
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
-26.35M
Income tax
Net income
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
-26.35M
Net income continuous Operations
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
---15.47M
---13.09M
---11.14M
-9.65%-28.89M
---8.5M
---26.35M
Minority interest income
Net income attributable to the parent company
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
-26.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
-26.35M
Basic earnings per share
-108.93%-0.67
-159.36%-1.12
-32.06%-1.4787
-53.76%-0.5063
-0.3788
-0.3207
-0.4318
-9.65%-1.1197
-0.3293
-1.0212
Diluted earnings per share
-108.93%-0.67
-159.36%-1.12
-32.06%-1.4787
-53.76%-0.5063
-0.3788
-0.3207
-0.4318
-9.65%-1.1197
-0.3293
-1.0212
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 000000024.20%7.03M282K5.66M
Operating revenue --0--0--0--0--0--0--024.20%7.03M--282K--5.66M
Cost of revenue
Gross profit
Operating expense 151.35%33.44M156.51%29.36M71.40%62.41M136.03%21.38M16.28M13.3M11.45M13.77%36.41M9.06M32M
Selling and administrative expenses 111.05%6.11M151.72%6.88M55.90%12.48M111.76%4.21M--2.64M--2.9M--2.73M30.20%8.01M--1.99M--6.15M
-General and administrative expense 111.05%6.11M151.72%6.88M55.90%12.48M111.76%4.21M--2.64M--2.9M--2.73M30.20%8.01M--1.99M--6.15M
Research and development costs 162.58%27.32M158.02%22.48M75.77%49.92M142.86%17.16M--13.64M--10.41M--8.71M9.86%28.4M--7.07M--25.85M
Operating profit -151.35%-33.44M-156.51%-29.36M-112.38%-62.41M-143.61%-21.38M-16.28M-13.3M-11.45M-11.53%-29.38M-8.78M-26.35M
Net non-operating interest income expense 2,035.32%4.66M782.30%2.69M319.00%2.1M189.84%742K830K218K305K25,100.00%500K256K-2K
Non-operating interest income 1,678.03%4.69M683.67%2.74M303.89%2.28M165.66%789K--880K--264K--349K56,400.00%565K--297K--1K
Non-operating interest expense -15.22%39K0.00%44K187.69%187K14.63%47K--50K--46K--44K2,066.67%65K--41K--3K
Other net income (expense) -228.57%-23K-766.67%-26K-511.11%-55K-239.13%-32K-13K-7K-3K-350.00%-9K23K-2K
Other non- operating income (expenses) -228.57%-23K-766.67%-26K-511.11%-55K-239.13%-32K---13K---7K---3K-350.00%-9K--23K---2K
Income before tax -120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M-26.35M
Income tax
Net income -120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M-26.35M
Net income continuous Operations -120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M---15.47M---13.09M---11.14M-9.65%-28.89M---8.5M---26.35M
Minority interest income
Net income attributable to the parent company -120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M-26.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M-26.35M
Basic earnings per share -108.93%-0.67-159.36%-1.12-32.06%-1.4787-53.76%-0.5063-0.3788-0.3207-0.4318-9.65%-1.1197-0.3293-1.0212
Diluted earnings per share -108.93%-0.67-159.36%-1.12-32.06%-1.4787-53.76%-0.5063-0.3788-0.3207-0.4318-9.65%-1.1197-0.3293-1.0212
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg